{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:47Z","timestamp":1760189147923,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The recombinant interleukin-2 (rIL-2) generation of lymphokine-activated killer (LAK) cells wasinvestigated in peripheral blood T lymphocytes (PBT) of 16 patients with monoclonal gammopathyof undetermined significance (MGUS) and 32 patients with multiple myeloma (MM). LAK activitywas significantly decreased in MM. but not in MGUS patients, and was partially recovered in MM inthe remission phase. This finding was unexpected, because CD8+ CD11b+ cells, which contain LAKprecursors, are significantly increased in MM. LAK activity was investigated in purifiedCD8+ CD11b+ lymphocytes to discriminate between an intrinsic defect or a defective regulation byother T cell subsets. These cells were intrinsically unable to generate LAK activity fully followingrIL-2 stimulation. MM showed the more pronounced LAK deficiency, while MGUS patients showedintermediate values. Phenotyping revealed significantly increased proportions of Leu7+ and HLA-DR+ cells in MM patients. These data reveal another dysregulation of T cell effector functions inpatients with monoclonal gammopathies and offer further evidence of the impairment of their cell-mediated immunity.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05134.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T09:52:21Z","timestamp":1280224341000},"page":"100-104","source":"Crossref","is-referenced-by-count":18,"title":["Defective interleukin-2 induction of lymphokine-activatedkiller (LAK) activity in peripheral blood T lymphocytesof patients with monoclonal gammopathies"],"prefix":"10.1093","volume":"79","author":[{"given":"M","family":"MASSAIA","sequence":"first","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"BIANCHI","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"DIANZANI","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"CAMPONI","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"ATTISANO","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"BOCCADORO","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"PILERI","sequence":"additional","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Haematology, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713430684100_b1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V51.6.1005.1005","article-title":"Unmaintained remission in multiple myeloma.","volume":"51","author":"Alexanian","year":"1978","journal-title":"Blood."},{"key":"2022011713430684100_b2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1984.tb06116.x","article-title":"Low plasma cell3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remissionphase myeloma: a reliable indicator of patients not requiring therapy","volume":"58","author":"Boccadoro","year":"1984","journal-title":"Br. J. Haematol."},{"key":"2022011713430684100_b3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00917143","article-title":"Characterization orhuman lymphocyte subpopulations: alloreactive cytotoxic T lymphocyte precursor and effector cells are phenotypically distinct fromLcu2+ suppressor cells","volume":"4","author":"Clement","year":"1984","journal-title":"J. clin. Immunol."},{"key":"2022011713430684100_b4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.4049\/jimmunol.133.5.2461","article-title":"Morphologicand phenotypic features of the subpopulation of Leu2+ cells thatsuppress B-cell differentiation","volume":"133","author":"Clement","year":"1984","journal-title":"J. Immunol."},{"key":"2022011713430684100_b5","first-page":"145","article-title":"Proposed guidelines for protocolstudies. II. Plasma cell myeloma.","volume":"4","author":"Committee of the Chronic Leukemia-MyelomaTaskForce, National Cancer Institute","year":"1973","journal-title":"Cancer Chemother. Rep."},{"key":"2022011713430684100_b6","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.137.9.2814","article-title":"lnterleukin 2-activated human killer cells are derived from phenotypically heteregeneous precursors","volume":"137","author":"Damle","year":"1986","journal-title":"J. Immunol."},{"key":"2022011713430684100_b7","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.4049\/jimmunol.131.5.2296","article-title":"Alloantigen-specific cytotoxic and suppressor T lymphocytesare derived from phenotypically distinct precursors","volume":"131","author":"Damle","year":"1983","journal-title":"J. Immunol."},{"key":"2022011713430684100_b8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00199953","article-title":"Surface markers and cytotoxicactivities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma","volume":"25","author":"De Rossi","year":"1987","journal-title":"Cancer Immunol. Immunother."},{"key":"2022011713430684100_b9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4049\/jimmunol.137.2.484","article-title":"Differential expression of ecto-5\u2032nucleotidase activity byfunctionally and phenotypically distinct subpopulations of humanLeu2+\/T8+ lymphocytes","volume":"137","author":"Dianzani","year":"1986","journal-title":"J. Immunol."},{"key":"2022011713430684100_b10","first-page":"400","article-title":"Biochemical evidence for the presence of abnormalB lymphocytes in the peripheral blood of multiple myeloma patients","volume":"24","author":"Dianzani","year":"1987","journal-title":"Ala. J. med. Sei."},{"key":"2022011713430684100_b11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood.V72.3.1064.bloodjournal7231064","article-title":"Activated idiotype-reactive lymphocytes in suppressor\/cytotoxic subpopulations of patients with monoclonal gammopathies:correlation with diagnosis and disease status","volume":"72","author":"Dianzani","year":"1988","journal-title":"Blood."},{"key":"2022011713430684100_b12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/eji.1830190613","article-title":"CD8+CD1lb+ peripheralblood T lymphocytes contain lymphokine-activated killer (LAK) cellprecursors","volume":"19","author":"Dianzani","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"2022011713430684100_b13","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.4049\/jimmunol.131.6.2757","article-title":"Characterization of a phenotypically distinct subpopulation of Leu2+ cells thatsuppresses T cell proliferative responses","volume":"131","author":"Landay","year":"1983","journal-title":"J. Immunol."},{"key":"2022011713430684100_b14","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4049\/jimmunol.131.4.1789","article-title":"Subpopulations of human natural killer cells defined by expression of the Lcu7 (HNK-1) and Leul1 (NK-15) antigens","volume":"131","author":"Lanier","year":"1983","journal-title":"J.Immunol."},{"issue":"Suppl. A","key":"2022011713430684100_b15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0305-7372(88)90073-4","article-title":"Recombinant interferon alpha-2b(INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.","volume":"15","author":"Mandelli","year":"1988","journal-title":"Cancer Treat. Rev."},{"key":"2022011713430684100_b16","first-page":"426","article-title":"Multiple myeloma: ecto-5\u2032nucleotidase deficiency ofsuppressor\/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells","volume":"69","author":"Massaia","year":"1987","journal-title":"Clin. exp. Immunol."},{"key":"2022011713430684100_b17","first-page":"214","article-title":"Defective generation of alloreactive cytotoxicT lymphocytes (CTL) in human monoclonal gummoputhies.","volume":"73","author":"Massaia","year":"1988","journal-title":"Clin. exp. Immunol."},{"key":"2022011713430684100_b18","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.141.11.3768","article-title":"The generation of alloreaclivc cytotoxic Tlymphocytes requires the expression of ecto-5\u2032nucleotidase activity.","volume":"141","author":"Massaia","year":"1988","journal-title":"J.Immunol."},{"key":"2022011713430684100_b19","first-page":"89","article-title":"Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma:correlation with the expansion of suppressor T-cells(CD8+ OKM 1+) and ecto-5\u2032nucleotidase deficiency.","volume":"26","author":"Massaia","year":"1988","journal-title":"J. clin. Lab. Immunol."},{"key":"2022011713430684100_b20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.164.4.1193","article-title":"Lymphokine-activated killer cells. Analysis of progenitors and effectors","volume":"164","author":"Ortaldo","year":"1986","journal-title":"J. exp. Med."},{"key":"2022011713430684100_b21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4049\/jimmunol.133.2.779","article-title":"Effects of natural and recombinanl IL2 on regulation of IFN-gammaproduction and natural killer activity: lack of involvement of the Tacantigen for these immunoregulatory effects.","volume":"133","author":"Ortaldo","year":"1984","journal-title":"J. Immunol."},{"key":"2022011713430684100_b22","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.4049\/jimmunol.139.11.3886","article-title":"Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysisof precursor frequency and effector phenotype","volume":"139","author":"Patel","year":"1987","journal-title":"J. Immunol."},{"key":"2022011713430684100_b23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V73.4.1020.1020","article-title":"The human myeloma cell line LP-1: aversatile model in which to study early plasma cell differentiation anilc-myc activation","volume":"73","author":"Pegoraro","year":"1989","journal-title":"Blood"},{"key":"2022011713430684100_b24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.164.3.814","article-title":"Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheralblood natural killer cells and T lymphocytes to cytolysis.","volume":"164","author":"Phillips","year":"1986","journal-title":"J. exp. Med."},{"key":"2022011713430684100_b25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.3095922","article-title":"Novel interleukin-2 receptor subunit detected bycross-linking under high-affinity conditions","volume":"234","author":"Sharon","year":"1986","journal-title":"Science"},{"key":"2022011713430684100_b26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0008-8749(88)90103-7","article-title":"CD11 molecule defines two types of suppressorcells within the T8+ population","volume":"111","author":"Takeuchi","year":"1988","journal-title":"Cell. Immunol."},{"key":"2022011713430684100_b27","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1073\/pnas.83.24.9694","article-title":"Demonstration of a non-Tac peptide that binds interleukin 2: apotential participant in a multichain interleukin 2 receptor complex","volume":"83","author":"Tsudo","year":"1986","journal-title":"Proc. natl. Acad. Set. USA."},{"key":"2022011713430684100_b28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910340314","article-title":"Strong natural killer (NK) cell activity in bone marrow ofmyeloma patients: accelerated maturation of bone marrow NK cellsand their interaction with other bone marrow cells.","volume":"34","author":"Uchida","year":"1984","journal-title":"Int. J. Cancer"},{"key":"2022011713430684100_b29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4049\/jimmunol.118.1.355","article-title":"Natural cytotoxic reactivity of human lymphocytesagainst a myeloid cell line: characterization of the effector cells","volume":"118","author":"West","year":"1977","journal-title":"J.Immunol."}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05134.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/79\/1\/100\/42218270\/j.1365-2249.1990.tb05134.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/79\/1\/100\/42218270\/j.1365-2249.1990.tb05134.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T11:52:43Z","timestamp":1740311563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/79\/1\/100\/6488970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05134.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"type":"electronic","value":"1365-2249"},{"type":"print","value":"0009-9104"}],"subject":[],"published-other":{"date-parts":[[1990,1]]},"published":{"date-parts":[[1990,1]]}}}